Solid phase sandwich ELISA for the determination of human LRG in serum, EDTA plasma, urine and cerebrospinal fluid. For research use only, not for use in diagnostic procedures.<br><br>
Among the diseases which should be distinguished from iNPH (idiopathic normal pressure hydrocephalus) of elderly people showing symptoms such as gait disorder and dementia, there are some neurodegenerative diseases such as Alzheimer's disease (AD), FTLD (frontotemporal lobar degeneration) and disorder associated with Parkinson's disease. This ELISA kit can measure LRG in CSF, blood or urine. It has become possible to distinguish iNPH from neurodegenerative diseases such as AD by measuring LRG in CSF.
- Assay Description:
- Overnight incubation (4°C) + 30 min. (37°C) + 30 minutes (RT) = Overnight + 1 hour total incubation time
- Catalog number:
- 27769
- configuration:
- 96 Determinations, 12x8 removable strips
- controls:
- None provided
- design:
- Solid phase sandwich ELISA using 2 kinds of high specific antibodies
- FDA Status:
- For research use only, not for use in diagnostic procedures
- MSDS:
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Protocol:
- Sample types:
- Serum, EDTA plasma, urine, and cerebrospinal fluid. (€» Additional EIA buffer may be required depending on your sample type and is available for an additional charge. Please refer to the datasheet for the details
- Sample volume:
- 100 μL of properly diluted unknown / determination
- standards:
- 8 standards, serially diluted from 1 prepared lyophilized standard
- Standard range:
- 0 / 1.56 - 100 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 0.17 ng/mL
- Species:
- Human
- Additional info:
- References:
- Related Article:
